Sofie Co Dba Sofie
FDA Regulatory Profile
Sofie Co Dba Sofie has 1 FDA recall, 45 inspections, 0 510(k) clearances and 2 compliance actions on record.
- Latest recall
- D-1177-2023 · Class II · Aug 22, 2023
- Latest inspection
- Apr 21, 2026 · VAI
Reviewing Sofie Co Dba Sofie as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Check this supplier
Or check Sofie Co Dba Sofie yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Get a free API key
Summary
Record counts and when each FDA source was last refreshed
| Records | Count | Last refreshed | Source as of | Status |
| Recalls | 1 | Nov 4, 2026 (checked Nov 8, 2026, unchanged) | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 45 | Nov 9, 2026 | Newest record Oct 28, 2026 | Current |
| Compliance actions | 2 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Recent Recalls
| Number | Class | Product | Date |
| D-1177-2023 | Class II | Florbetaben F-18 (Neuraceq¿) Injection Solution 1.4 to 135 mCi/mL, 50 mL in 1 multi-dose glass vial… | Aug 22, 2023 |
Recent FDA Inspections
| Date | Site | Product | Classification | FEI |
| Apr 21, 2026 | Dallas, TX | Drugs | Voluntary Action Indicated (VAI) | 3008486071 |
| Jan 15, 2026 | Decatur, IL | Drugs | Voluntary Action Indicated (VAI) | 3009754344 |
| Oct 28, 2025 | Houston, TX | Drugs | Voluntary Action Indicated (VAI) | 3003932395 |
| Sep 3, 2025 | Kansas City, MO | Drugs | Voluntary Action Indicated (VAI) | 3008310003 |
| Aug 28, 2025 | Morgantown, WV | Drugs | Voluntary Action Indicated (VAI) | 3005705842 |
| Aug 7, 2025 | Gilroy, CA | Drugs | Voluntary Action Indicated (VAI) | 3006246010 |
| Jul 25, 2025 | Sterling, VA | Drugs | Voluntary Action Indicated (VAI) | 3004977184 |
| Jul 12, 2024 | Romeoville, IL | Drugs | Voluntary Action Indicated (VAI) | 3008297570 |
| Jan 22, 2024 | Sanford, FL | Drugs | Voluntary Action Indicated (VAI) | 3008302967 |
| Aug 11, 2023 | Totowa, NJ | Drugs | Voluntary Action Indicated (VAI) | 3008415560 |
| Jan 20, 2023 | Somerset, NJ | Drugs | Voluntary Action Indicated (VAI) | 3005705951 |
| Sep 22, 2021 | Sanford, FL | Drugs | Official Action Indicated (OAI) | 3008302967 |
| Apr 12, 2019 | Sanford, FL | Drugs | Official Action Indicated (OAI) | 3008302967 |
| Feb 5, 2019 | Gilroy, CA | Drugs | Voluntary Action Indicated (VAI) | 3006246010 |
| Jan 22, 2019 | Kansas City, MO | Drugs | Voluntary Action Indicated (VAI) | 3008310003 |
| Jan 15, 2019 | Dallas, TX | Drugs | Voluntary Action Indicated (VAI) | 3008486071 |
| Dec 3, 2018 | Sterling, VA | Drugs | Voluntary Action Indicated (VAI) | 3004977184 |
| Jun 28, 2017 | Totowa, NJ | Drugs | No Action Indicated (NAI) | 3008415560 |
| Jan 4, 2017 | Houston, TX | Drugs | No Action Indicated (NAI) | 3003932395 |
| Aug 17, 2016 | Decatur, IL | Drugs | No Action Indicated (NAI) | 3009754344 |
NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.
FDA-Inspected Facilities
| Facility | Location | Inspections | Latest |
| FEI 3008486071 | Dallas, TX | 4 | Apr 21, 2026 |
| FEI 3009754344 | Decatur, IL | 4 | Jan 15, 2026 |
| FEI 3003932395 | Houston, TX | 4 | Oct 28, 2025 |
| FEI 3008310003 | Kansas City, MO | 4 | Sep 3, 2025 |
| FEI 3005705842 | Morgantown, WV | 4 | Aug 28, 2025 |
| FEI 3006246010 | Gilroy, CA | 4 | Aug 7, 2025 |
| FEI 3004977184 | Sterling, VA | 5 | Jul 25, 2025 |
| FEI 3008297570 | Romeoville, IL | 4 | Jul 12, 2024 |
| FEI 3008302967 | Sanford, FL | 4 | Jan 22, 2024 |
| FEI 3008415560 | Totowa, NJ | 4 | Aug 11, 2023 |
| FEI 3005705951 | Somerset, NJ | 4 | Jan 20, 2023 |